{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:25Z","timestamp":1793042785223,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jad.2026.121499","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:51:49Z","timestamp":1771865509000},"page":"121499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The efficacy of lumateperone across symptoms of a major depressive episode with mixed features in patients with major depressive disorder and bipolar disorder: Post hoc analyses"],"prefix":"10.1016","volume":"404","author":[{"given":"Lakshmi N.","family":"Yatham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Kozauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie R.","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Durgam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121499_bb0005","series-title":"Vraylar. (Prescribing information)","author":"Allergan","year":"2022"},{"key":"10.1016\/j.jad.2026.121499_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jad.2026.121499_bb0015","series-title":"Seroquel XR. (Prescribing information)","author":"AstraZeneca Pharmaceuticals","year":"2022"},{"key":"10.1016\/j.jad.2026.121499_bb0020","series-title":"Seroquel. (Prescribing information)","author":"AstraZeneca Pharmaceuticals","year":"2022"},{"key":"10.1016\/j.jad.2026.121499_bb0025","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1017\/S146114571300031X","article-title":"Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy","volume":"16","author":"Bauer","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121499_bb0030","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.121499_bb0040","series-title":"Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health","first-page":"7","article-title":"Rating scales for depression","author":"Cusin","year":"2009"},{"key":"10.1016\/j.jad.2026.121499_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.ajp.2015.15020164","article-title":"An 8-week randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression","volume":"173","author":"Durgam","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0000000000001964","article-title":"Lumateperone for the treatment of major depressive disorder with mixed features or bipolar depression with mixed features: a randomized placebo-controlled trial","volume":"45","author":"Durgam","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121499_bb0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/psychiatry.IndianJPsychiatry_760_19","article-title":"Prevalence and clinical correlates of residual symptoms in remitted patients with bipolar disorder: an exploratory study","volume":"62","author":"Grover","year":"2020","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psychres.2005.10.009","article-title":"Development and reliability of the HAM-D\/MADRS interview: an integrated depression symptom rating scale","volume":"145","author":"Iannuzzo","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.121499_bb0065","series-title":"Caplyta. (Prescribing information)","author":"Intra-Cellular Therapies Inc.","year":"2023"},{"key":"10.1016\/j.jad.2026.121499_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11136-021-02929-8","article-title":"Quality of life and subjective sleep-related measures in bipolar disorder and major depressive disorder","author":"Jermann","year":"2022","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jad.2026.121499_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jad.2017.11.028","article-title":"Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression","volume":"227","author":"Lorenzo-Luaces","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121499_bb5000","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"Marx","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jad.2026.121499_bb0085","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4088\/JCP.08m04942gre","article-title":"A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)","volume":"71","author":"McElroy","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0090","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1080\/03007995.2019.1636017","article-title":"Bipolar depression: the clinical characteristics and unmet needs of a complex disorder","volume":"35","author":"McIntyre","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2026.121499_bb0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.euroneuro.2022.12.012","article-title":"The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: secondary and post hoc analyses","volume":"68","author":"McIntyre","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121499_bb0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2014.09.026","article-title":"The prevalence and illness characteristics of DSM-5-defined \u201cmixed feature specifier\u201d in adults with major depressive disorder and bipolar disorder: results from the International Mood Disorders Collaborative Project","volume":"172","author":"McIntyre","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121499_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200822050-00003","article-title":"Burden of bipolar depression: impact of disorder and medications on quality of life","volume":"22","author":"Michalak","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2026.121499_bb0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery\u2013\u00c5sberg depression rating scale (MADRS)","volume":"77","author":"M\u00fcller","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121499_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2017.09.054","article-title":"Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: a post hoc analysis of two pooled clinical studies","volume":"227","author":"Nelson","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121499_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR* D report","volume":"40","author":"Nierenberg","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.121499_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/pcn.12214","volume":"69","author":"Ozaki","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.121499_bb0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00213-014-3704-1","article-title":"Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission","volume":"232","author":"Snyder","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2026.121499_bb0140","doi-asserted-by":"crossref","unstructured":"Stahl, S.M., Morrissette, D.A., Faedda, G., Fava, M., Goldberg, J.F., Keck, P.E., Lee, Y., Malhi, G., Marangoni, C., McElroy, S.L., Ostacher, M., Rosenblat, J.D., Sole, E., Suppes, T., Takeshima, M., Thase, M.E., Vieta, E., Young, A., Zimmerman, M., McIntyre, R.S., 2017. Guidelines for the recognition and management of mixed depression. CNS Spectr. 22, 203-219. Marx, W., Penninx, B.W., Solmi, M., Furukawa, T.A., Firth, J., Carvalho A.F., Berk, M., 2023. Major depressive disorder. Nat. Rev. Dis. Primers. 9, 44.","DOI":"10.1017\/S1092852917000165"},{"key":"10.1016\/j.jad.2026.121499_bb0145","series-title":"Latuda. (Prescribing information)","author":"Sunovion Pharmaceuticals Inc.","year":"2022"},{"key":"10.1016\/j.jad.2026.121499_bb0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121499_bb0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121499_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.euroneuro.2022.06.009","article-title":"Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: a dopamine D1 receptor dependent mechanism","volume":"62","author":"Titulaer","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121499_bb0165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0170","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1017\/S146114571300028X","article-title":"Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies","volume":"16","author":"Trivedi","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121499_bb0175","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jad.2017.09.006","article-title":"Mixed symptoms in major depressive and bipolar disorders: a systematic review","volume":"225","author":"Vazquez","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121499_bb0180","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bdi.13135","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations","volume":"23","author":"Yatham","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.121499_bb0185","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.08m04995gre","article-title":"A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)","volume":"71","author":"Young","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121499_bb0190","first-page":"655","article-title":"Recognition and treatment of cognitive dysfunction in major depressive disorder","volume":"9","author":"Zuckerman","year":"2018","journal-title":"Front. Psychol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726003502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726003502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:27:10Z","timestamp":1777494430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726003502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"alternative-id":["S0165032726003502"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121499","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of lumateperone across symptoms of a major depressive episode with mixed features in patients with major depressive disorder and bipolar disorder: Post hoc analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121499"}}